The United Arab Emirates approves Sinopharm's vaccine for frontline workers following successful Phase III clinical trials in Abu Dhabi. The WHO-recognized trial began on July 16 and involved 31,000 volunteers.
The UAE has approved Sinopharm's COVID-19 vaccine for frontline workers following successful Phase III clinical trials in Abu Dhabi. "The results of studies during the final stages of the Phase III trial showed that the vaccine is effective and resulted in a strong response, and the generation of antibodies to the virus. Studies on the safety of the vaccination have been reviewed and showed that it is safe and safe for use." said Minister of Health Abdulrahman Al Owais. The WHO-recognized trial began on July 16 and involved 31,000 volunteers.
The UnitedArabEmirates approves Sinopharm's vaccine for frontline workers following successful Phase III clinical trials in Abu Dhabi. The WHO-recognized trial began on July 16 and involved 31,000 volunteers.
